Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
7601 - 7625 of 8824 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2024
  • 2020
  • 2020
  • 2020
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2022
  • 2022
  • Motor Thalamic Deep Brain Stimulation Alters Cortical Activity and Shows Therapeutic Utility for Treatment of Parkinson’s Disease Symptoms in a Rat Model
    2021
    Summary Details
    RESTRICTED
    Title: Motor Thalamic Deep Brain Stimulation Alters Cortical Activity and Shows Therapeutic Utility for Treatment of Parkinson’s Disease Symptoms in a Rat Model
    Author(s): Heidi R. Tucker, Emily Mahoney, Kainat Akhtar, Tzu‐Jen Kao, Gianna Mamone, Saisree Mikkilineni, Maya Ravi, Hanel Watkins, Danielle-Lee Terrelonge, Caryn Martin, Kristen Unger, Gabrielle Kim, Kyra Fiber, Megan Gupta, Jonathan Indajang, Eliyahu M. Kochman, Natasha Sachs, Paul J. Feustel, Eric Molho, Julie G. Pilitsis, Damian S. Shin
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Vol: 460
    Issue #:
    Start Page: 88
    End Page: 106
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.019
    Citation Count: 9
  • Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease
    2021
    Summary Details
    RESTRICTED
    Title: Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease
    Author(s): Cynthia Kwan, Imane Frouni, Stephen G. Nuara, Sébastien Belliveau, Woojin Kang, Adjia Hamadjida, Dominique Bédard, Francis Beaudry, Michel Panisset, Jim C. Gourdon, Philippe Huot
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Vol: 186
    Issue #:
    Start Page: 108465
    End Page: 108465
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108465
    Citation Count: 19
  • Une valine 11 codée par le gène HLA-DRB1 est associée inversement au risque de maladie de Parkinson et interagit avec l’initiation du tabagisme
    2022
    Summary Details
    RESTRICTED
    Title: Une valine 11 codée par le gène HLA-DRB1 est associée inversement au risque de maladie de Parkinson et interagit avec l’initiation du tabagisme
    Author(s): Cloé Domenighetti, Venceslas Douillard, Pierre‐Emmanuel Sugier, Nicolas Vince, Alexis Elbaz
    Journal Name: Revue Neurologique
    Publisher: Elsevier BV
    Vol: 178
    Issue #:
    Start Page: S15
    End Page: S15
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.151
    Citation Count: 0
  • La thérapie comportementale et cognitive pour l’anxiété dans la maladie de Parkinson induit des modifications cérébrales fonctionnelles
    2022
    Summary Details
    RESTRICTED
    Title: La thérapie comportementale et cognitive pour l’anxiété dans la maladie de Parkinson induit des modifications cérébrales fonctionnelles
    Author(s): Guillaume Carey, Renaud Lopes, J.H. Moonen Anja, Grégory Kuchcinski, Luc Defebvre, Kathy Dujardin, Albert F.G. Leentjens
    Journal Name: Revue Neurologique
    Publisher: Elsevier BV
    Vol: 178
    Issue #:
    Start Page: S15
    End Page: S15
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.152
    Citation Count: 0
  • Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellum
    2022
    Summary Details
    RESTRICTED
    Title: Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellum
    Author(s): Nathan Morelli
    Journal Name: Revue Neurologique
    Publisher: Elsevier BV
    Vol: 178
    Issue #: 9
    Start Page: 924
    End Page: 931
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurol.2022.05.002
    Citation Count: 6
  • Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain Stimulation
    2022
    Summary Details
    OPEN
    Title: Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain Stimulation
    Author(s): A. Langer, Lara Lucke-Paulig, Lucia Gassner, Rejko Krüger, Daniel Weiß, Alireza Gharabaghi, Heidemarie Zach, Walter Maetzler, Markus A. Hobert
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Vol: 26
    Issue #: 2
    Start Page: 364
    End Page: 373
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.015
    Citation Count: 5
  • ID:16203 Brachial Plexus Stimulation for Refractory Neuropathic Upper Limb Pain in a Traumatic Brain Injury Patient
    2022
    Summary Details
    RESTRICTED
    Title: ID:16203 Brachial Plexus Stimulation for Refractory Neuropathic Upper Limb Pain in a Traumatic Brain Injury Patient
    Author(s): Soun Sheen, Hemant Kalia
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Vol: 25
    Issue #: 5
    Start Page: S6
    End Page: S6
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.02.011
    Citation Count: 0
  • ID:16220 Visualization Tool for DBS Programming Used With a Multiple-Source, Constant-Current System Reduces Initial Programming Time
    2022
    Summary Details
    RESTRICTED
    Title: ID:16220 Visualization Tool for DBS Programming Used With a Multiple-Source, Constant-Current System Reduces Initial Programming Time
    Author(s): Jason Aldred, Theresa Zesiewicz, Michael S. Okun, Juan Ramirez‐Castaneda, Leo Verhagen-Metman, Corneliu Luca, Ritesh Ramdhani, Jennifer Durphy, Yarema Bezchlibnyk, Jonathan Carlson, Kelly D. Foote, Sepehr Sani, Alexander Papanastassiou, Jonathan Jagid, David A. Weintraub, Julie G. Pilitsis, Lilly Chen, Roshini Jain
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Vol: 25
    Issue #: 5
    Start Page: S6
    End Page: S7
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.02.012
    Citation Count: 0
  • Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies
    2024
    Summary Details
    OPEN
    Title: Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies
    Author(s): Sara Nagy, Aisling Carr, Magdalena Mroczek, Simon Rinaldi, Riccardo Curró, Natalia Dominik, Nicole Japzon, Francesca Magrinelli, Michael P. Lunn, Hadi Manji, Mary M. Reilly, Andrea Cortese, Henry Houlden
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Vol: 6
    Issue #: 4
    Start Page: fcae163
    End Page: fcae163
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae163
    Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae163/58040219/fcae163.pdf
    Citation Count: 1
  • Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodies
    2020
    Summary Details
    OPEN
    Title: Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodies
    Author(s): Andrea Sturchio, Matteo Gastaldi, Lucia Princiotta Cariddi, Daniela Biacchi, Alberto J. Espay, Diego Franciotta, Maurizio Versino, M. Mauri
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 82
    Issue #:
    Start Page: 7
    End Page: 9
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.008
    Best OA location URL: http://www.prd-journal.com/article/S1353802020308592/pdf
    Citation Count: 6
  • Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson’s disease
    2020
    Summary Details
    OPEN
    Title: Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson’s disease
    Author(s): Anna Inguanzo, Roser Sala‐Llonch, Bàrbara Segura, H. Erostarbe, Alexandra Abós, Anna Campabadal, Carme Uribe, Hugo C. Baggio, Yaroslau Compta, Marı́a José Martı́, Francesc Valldeoriola, Núria Bargalló, Carme Junqué
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 82
    Issue #:
    Start Page: 16
    End Page: 23
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.010
    Best OA location URL: http://www.prd-journal.com/article/S1353802020308609/pdf
    Citation Count: 56
  • Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)
    2020
    Summary Details
    OPEN
    Title: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)
    Author(s): Robert A. Hauser, Leonid Zeitlin, Stanley E. Fisher, Richard D’Souza
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 82
    Issue #:
    Start Page: 133
    End Page: 137
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002
    Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdf
    Citation Count: 7
  • Essential tremor and cognitive decline
    2021
    Summary Details
    RESTRICTED
    Title: Essential tremor and cognitive decline
    Author(s): Holly A. Shill, Shyamal H. Mehta, Charles H. Adler
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 83
    Issue #:
    Start Page: 125
    End Page: 125
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.012
    Citation Count: 3
  • Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study
    2021
    Summary Details
    OPEN
    Title: Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study
    Author(s): Christos Koros, Athina‐Maria Simitsi, Nikolaos Papagiannakis, Anastasia Bougea, Andreas Prentakis, Dimitra Papadimitriou, Ioanna Pachi, Roubina Antonelou, Efthalia Angelopoulou, Ion Beratis, Maria Bozi, Sokratis G. Papageorgiou, Xenia Geronicola Trapali, María Stamelou, Leonidas Stefanis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 84
    Issue #:
    Start Page: 1
    End Page: 4
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.020
    Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.12.020
    Citation Count: 19
  • Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
    2021
    Summary Details
    OPEN
    Title: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
    Author(s): Regina Katzenschlager, Werner Poewe, Olivier Rascol, Claudia Trenkwalder, Günther Deuschl, К. Ray Chaudhuri, Tove Henriksen, Teus van Laar, Donna Lockhart, Harry Staines, Andrew J. Lees
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 83
    Issue #:
    Start Page: 79
    End Page: 85
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024
    Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdf
    Citation Count: 78
  • Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progression
    2021
    Summary Details
    RESTRICTED
    Title: Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progression
    Author(s): Ryul Kim, Sangmin Park, Dallah Yoo, Jin‐Sun Jun, Beomseok Jeon
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 83
    Issue #:
    Start Page: 66
    End Page: 70
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.004
    Citation Count: 14
  • Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”
    2021
    Summary Details
    RESTRICTED
    Title: Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”
    Author(s): Christopher Kobylecki, Monty Silverdale
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 83
    Issue #:
    Start Page: 128
    End Page: 129
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.011
    Citation Count: 0
  • Genetic characterization of a cohort with familial parkinsonism and cognitive-behavioral syndrome: A Next Generation Sequencing study
    2021
    Summary Details
    RESTRICTED
    Title: Genetic characterization of a cohort with familial parkinsonism and cognitive-behavioral syndrome: A Next Generation Sequencing study
    Author(s): Marina Picillo, Monia Ginevrino, Giovanna Dati, Sara Scannapieco, Annamaria Vallelunga, Pietro Siano, Giampiero Volpe, Roberto Ceravolo, Valentina Nicoletti, Calogero Edoardo Cicero, Alessandra Nicoletti, Mario Zappia, Silvia Peverelli, Vincenzo Silani, Maria Teresa Pellecchia, Enza Maria Valente, Paolo Barone
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 84
    Issue #:
    Start Page: 82
    End Page: 90
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.024
    Citation Count: 2
  • Compound heterozygous variants in Wiskott-Aldrich syndrome like (WASL) gene segregating in a family with early onset Parkinson's disease
    2021
    Summary Details
    RESTRICTED
    Title: Compound heterozygous variants in Wiskott-Aldrich syndrome like (WASL) gene segregating in a family with early onset Parkinson's disease
    Author(s): Sumeet Kumar, Masoom M. Abbas, Shyla T. Govindappa, Uday B. Muthane, Madhuri Behari, Sanjay Pandey, Ramesh C. Juyal, B.K. Thelma
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 84
    Issue #:
    Start Page: 61
    End Page: 67
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.001
    Citation Count: 19
  • White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease
    2021
    Summary Details
    RESTRICTED
    Title: White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease
    Author(s): Mahsa Dadar, Janis M. Miyasaki, Simon Duchesne, Richard Camicioli
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 85
    Issue #:
    Start Page: 95
    End Page: 101
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.031
    Citation Count: 20
  • Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database
    2021
    Summary Details
    OPEN
    Title: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database
    Author(s): Lucas Udovin, Matilde Otero‐Losada, Sofía Bordet, Guenson Chevalier, Cecilia Quarracino, Francisco Capani, Santiago Pérez-Lloret
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 86
    Issue #:
    Start Page: 34
    End Page: 37
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007
    Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625
    Citation Count: 21
  • Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores
    2021
    Summary Details
    OPEN
    Title: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores
    Author(s): Johann Faouzi, Baptiste Couvy‐Duchesne, Samir Bekadar, Olivier Colliot, Jean‐Christophe Corvol
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 86
    Issue #:
    Start Page: 74
    End Page: 77
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003
    Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298502
    Citation Count: 11
  • Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common Marmoset
    2021
    Summary Details
    RESTRICTED
    Title: Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common Marmoset
    Author(s): Cynthia Kwan, Min Su Kang, Stephen G. Nuara, Jim C. Gourdon, Dominique Bédard, Christine Tardif, Robert Hopewell, Karen Ross, Hussein Bdair, Adjia Hamadjida, Gassan Massarweh, Jean‐Paul Soucy, Wen Luo, Esther del Cid‐Pellitero, Irina Shlaifer, Thomas M. Durcan, Edward A. Fon, Pedro Rosa‐Neto, Stephen Frey, Philippe Huot
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Vol: 480
    Issue #:
    Start Page: 143
    End Page: 154
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.11.009
    Citation Count: 12
  • Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic Neurons
    2022
    Summary Details
    RESTRICTED
    Title: Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic Neurons
    Author(s): Maria Argyrofthalmidou, Alexia Polissidis, Sevasti Karaliota, Ioanna Papapanagiotou, Evangelos Sotiriou, Maria Manousaki, Z. Papadopoulou‐Daifoti, Maria Grazia Spillantini, Leonidas Stefanis, Demetrios K. Vassilatis
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Vol: 506
    Issue #:
    Start Page: 114
    End Page: 126
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2022.10.011
    Citation Count: 2
  • Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach
    2022
    Summary Details
    RESTRICTED
    Title: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach
    Author(s): Dia Advani, Pravir Kumar
    Journal Name: Neuropeptides
    Publisher: Elsevier BV
    Vol: 96
    Issue #:
    Start Page: 102283
    End Page: 102283
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.